Curated by Peter Schulte · Published 2026-06-24 · Last updated 2026-06-24
The story of human health is, against all odds, a story of compounding progress.
Child mortality has fallen from nearly 50% across most of human history to levels once unimaginable. Smallpox — a disease that killed up to 30% of its victims — was erased from the planet. Africa eliminated wild polio. Malaria vaccines reached children in sub-Saharan Africa and Sudan. Blood lead levels in Americans fell 100-fold in a century.
These are not isolated flukes. They reflect a repeating pattern: scientific discovery, translated into policy, scaled through international cooperation, and sustained by communities on the ground.
In 2026, the momentum is accelerating — mRNA technology is being aimed at cancer, a nasal spray cut stroke brain damage by 80% in preclinical trials, and lenacapavir prevents HIV transmission in more than 99.9% of participants. The arc of public health bends, slowly and unevenly, toward survival.
Key takeaways
- Smallpox was fully eradicated in 1980 — the only human infectious disease ever eliminated — and wild polio has since been beaten across all of Africa.
- Global child mortality fell from ~48% across most of human history to 27% by 1950 and has continued dropping; global life expectancy gained more than a decade between 1980 and 2015.
- mRNA vaccine technology, proven by COVID-19, is now in human trials for lung cancer and showing six-year survival results in pancreatic cancer.
- Lenacapavir, a twice-yearly HIV prevention shot, stops transmission in over 99.9% of participants and will be made cheaply available in 120 countries.
- Public health wins increasingly combine cutting-edge science with equity: Mexico launched universal healthcare for 133 million citizens, Botswana cut mother-to-child HIV transmission from 40% to below 1%, and malaria vaccine price cuts will protect 7 million more children by 2030.
Recovery at a glance
| Subject | Recovery | Where |
|---|---|---|
| Smallpox | First infectious disease fully eradicated | Global |
| Wild poliovirus | Africa certified free after 95%+ immunization | Africa |
| Lenacapavir (HIV PrEP) | 99.9%+ prevention rate; FDA-approved twice-yearly shot | USA / 120 countries |
| Botswana mother-to-child HIV | Transmission rate fell from 40% to below 1% | Botswana |
| Global suicide rate | Down nearly 40% since the early 1990s | Global |
| U.K. cancer death rates | Down more than 25% over two decades — lowest ever recorded | United Kingdom |
| Dostarlimab (rectal cancer) | Eliminated tumors in all 42 trial patients | USA |
| Global life expectancy | Crossed 50 years for first time (~1955); gained 10+ years by 2015 | Global |
| Nepal rubella | WHO-confirmed elimination — sixth nation in SE Asia Region | Nepal |
| Sudan malaria vaccine | First country in WHO Eastern Mediterranean Region to launch nationally | Sudan |
| Blood lead levels (USA) | Fallen roughly 100-fold over a century | USA |
| Flint lead pipes | All 11,000 lead service lines replaced | Flint, Michigan, USA |
| Finland teen abortion rate | Down 66% after free contraception rollout | Finland |
| Mexico universal healthcare | All 133 million citizens now covered | Mexico |
| Malaria (WHO 1955 campaign) | Eliminated from 37 countries by 1969 | Global |
| Guatemala river blindness | Fourth country to achieve full elimination | Guatemala |
On this page
- Why this matters
- What’s driving the comeback
- Ancient foundations: the long prehistory of public health wins
- Scientific revolutions: the discoveries that changed medicine forever
- Eradication and elimination: diseases driven to zero
- Vaccines and immunization: from first shots to global rollouts
- Drug approvals and treatment breakthroughs: medicines changing outcomes
- Diagnostics, research tools, and frontier science
- Population health, equity, and the systems that protect everyone
- The outlook
- Frequently asked questions
Why this matters
The scale of the public health transformation since the mid-20th century is difficult to overstate. A child born today in almost any country faces radically lower odds of dying before age five than at any prior point in recorded history — a shift driven not by luck but by deliberate, coordinated human action.
The milestones in this collection span 4,600 years of medical history, from the Edwin Smith Papyrus to 2026 FDA approvals. But the acceleration since 1950 is extraordinary: smallpox gone, polio retreating, malaria vaccines deployed, cancer immunotherapy rewriting survival odds.
What makes this moment different is convergence. mRNA technology, genomic diagnostics, stem cell therapies, and long-acting injectables are arriving simultaneously — while equity-focused programs are beginning to close the gap between rich and poor countries.
By the numbers
- Smallpox killed up to 30% of those it infected before being fully eradicated in 1980.
- Africa’s wild polio elimination prevented an estimated 1.8 million cases of paralysis.
- Global suicide rates fell nearly 40% — from roughly 15 to around 9 per 100,000 — since the early 1990s.
- Botswana cut mother-to-child HIV transmission from 40% in 1999 to below 1% today.
- U.K. cancer death rates dropped more than 25% over two decades, reaching their lowest level ever recorded.
- Lenacapavir stopped HIV transmission in more than 99.9% of clinical trial participants.
- A 25% malaria vaccine price cut will extend protection to an estimated 7 million more children by 2030.
What’s driving the comeback
Protected, well-funded scientific institutions have repeatedly been the origin point — Fleming’s penicillin discovery, Schatz’s streptomycin isolation, Banting and Best’s insulin extraction. But discovery alone is never enough; it is the translation into scalable public programs that saves lives at scale.
International coordination multiplies impact dramatically. The WHO’s 1955 malaria eradication campaign eliminated the disease from 37 countries. Nelson Mandela’s ‘Kick Polio Out of Africa’ built the political will for a continental immunization drive. UNICEF’s logistics made Sudan’s malaria vaccine rollout possible even as hospitals operated under conflict conditions.
Equity mechanisms — generic licensing, price negotiations, community health workers — determine whether breakthroughs reach the people who need them most. Botswana’s near-elimination of mother-to-child HIV relied on free testing and free antiretrovirals, not just good science. Lenacapavir’s 120-country generic licensing deal is the same logic applied to prevention.
Ancient foundations: the long prehistory of public health wins
Every modern vaccine and surgical technique stands on a foundation built across millennia. These stories reveal that the impulse to systematize medical knowledge — to write it down, share it, and improve on it — is as old as civilization itself, and that even ancient innovations carry direct lines to present-day practice.
The world’s first written cancer diagnosis, 2650 B.C.E.
The Edwin Smith Papyrus, written around 2650 B.C.E., contains the oldest known written diagnosis of cancer, describing hard tumors of the breast across 48 carefully documented cases. The scribe’s methodical approach — observe, name, assess — established a template for clinical documentation that endures today.
The Sushruta Samhita: 300+ surgical procedures from ancient India
Completed between 300 and 500 C.E., the Suśrutasaṃhitā catalogs more than 300 surgical procedures and 120 instruments, including a rhinoplasty technique European surgeons would independently rediscover centuries later. It represents one of history’s most sophisticated pre-modern medical texts.
Hippocratic ethics: medicine’s first code of care
Written in the fourth or fifth century B.C.E., the Hippocratic Oath bound physicians to their patients through principles of care, confidentiality, and restraint. Though the famous phrase ‘first, do no harm’ came later, this tradition embedded ethics into medicine’s DNA at its founding.
Ibn Sina’s Canon of Medicine unifies global medical knowledge
Completed in 1025 C.E., Ibn Sina’s five-volume Canon synthesized Greek, Persian, Indian, and Chinese medical knowledge into a single authoritative reference. Translated into Latin in 12th-century Toledo, it became a standard medical textbook in European universities for centuries.
Toilet paper and the early history of sanitation
Around 589 C.E., Chinese scholar Yan Zhitui recorded what appears to be the earliest known reference to toilet paper — and did so in a tone suggesting the practice was already commonplace. The offhand mention points to how sanitation practices were quietly shaping public health long before germ theory arrived.
Hanaoka Seishū performs the first surgery under general anesthesia
In October 1804, Japanese surgeon Hanaoka Seishū removed part of a patient’s breast tumor while she slept under an herbal anesthetic he had spent two decades perfecting. It stands as the first documented surgery under general anesthesia anywhere in the world.
Scientific revolutions: the discoveries that changed medicine forever
A handful of laboratory moments — a mold contaminating a petri dish, a hormone extracted from a dog’s pancreas, a soil microbe cultured in a basement — fundamentally altered the odds of human survival. These breakthrough discoveries share a common structure: a prepared mind, an unexpected observation, and years of painstaking work before a discovery becomes a medicine.
Pasteurization: Louis Pasteur’s quiet revolution in food safety
In 1864, Louis Pasteur demonstrated that gentle, precise heat could kill the microorganisms spoiling wine and beer — a principle that was later applied to milk with dramatic effects on child survival. Chicago’s milk pasteurization mandate became a model for public health regulation worldwide.
Fleming’s penicillin discovery launches the age of antibiotics
On September 28, 1928, Alexander Fleming returned from holiday to find a stray mold dissolving bacteria on one of his petri dishes. It took an Oxford team another decade to turn that curiosity into medicine, but by World War II, the discovery was saving lives on a massive scale.
Howard Florey’s team gives penicillin its first human trial
In February 1941, Howard Florey’s Oxford team treated a dying police constable with penicillin, achieving dramatic improvement before the drug ran out and the patient ultimately died. The experiment still opened the door to clinical antibiotic use and set the template for modern drug trials.
Albert Schatz isolates streptomycin — the first TB cure
On October 19, 1943, 23-year-old PhD student Albert Schatz isolated streptomycin from a soil microbe in a Rutgers University basement, producing the first antibiotic capable of killing tuberculosis. The discovery offered a cure for a disease that had stalked humanity since antiquity.
Insulin discovery gives life back to millions with diabetes
In the summer of 1921, Frederick Banting and Charles Best extracted insulin from a dog’s pancreas in Toronto, then used it to transform a 14-year-old boy’s diabetes from a death sentence into a manageable condition. The discovery remains one of medicine’s most life-altering single moments.
The first cancer chemotherapy patient in history
On August 27, 1942, a Polish immigrant known only as JD received the first injection of cancer chemotherapy at Yale–New Haven Hospital, and his lymphoma shrank measurably. Though he died 96 days later, that brief remission proved the radical idea that chemistry could fight cancer.
William Cullen demonstrates the first artificial refrigeration
In 1755, Scottish physician William Cullen used a vacuum pump to produce a thin crust of ice — demonstrating the principle of artificial refrigeration for the first time. The principle he glimpsed would eventually underpin the cold chains that make modern vaccine distribution possible.
Nicolas Appert’s food preservation solves a problem as old as hunger
In 1809, French confectioner Nicolas Appert discovered that food cooked inside a sealed glass jar did not spoil, winning a 12,000-franc government prize in the process. His method laid the groundwork for food safety at scale, prefiguring the canning and preservation industries that would feed armies and cities.
Eradication and elimination: diseases driven to zero
The complete elimination of a disease from a population — or from the planet — represents the highest possible achievement in public health. These stories share a common architecture: mass immunization, relentless surveillance, international coordination, and the political will to finish the job even when the end seems distant.
Smallpox: the only human disease ever fully eradicated
Smallpox was declared eradicated on May 8, 1980, ending a disease that had killed up to 30% of those it infected for at least 3,000 years. The WHO’s campaign paired mass vaccination with intensive case-tracking led by local health workers — a model that still guides elimination efforts today.
Africa declared free of wild polio after continental immunization drive
Africa was certified free of wild poliovirus after more than 95% of the continent’s population was immunized, preventing an estimated 1.8 million cases of paralysis. The campaign traced its political origins to Nelson Mandela’s 1996 ‘Kick Polio Out of Africa’ initiative.
WHO launches the world’s first global malaria eradication programme
In the spring of 1955, the World Health Assembly voted to coordinate the first planet-wide campaign against malaria. By the time the effort was suspended in 1969, malaria had been eliminated from 37 countries — a record of collective action with few parallels in public health history.
Guatemala becomes the fourth country to eliminate river blindness
In September 2016, Guatemala was declared free of river blindness, ending a parasitic disease that had threatened sight and livelihoods in rural communities for generations. The victory came after more than 20 years of twice-yearly Mectizan treatments reaching at least 85% of at-risk communities.
Sri Lanka’s malaria-free certification puts 30+ nations on a path to elimination
Sri Lanka was certified malaria-free in 2016, a hard-won milestone achieved despite years of civil conflict through mobile clinics and rapid childhood diagnosis. The country had never previously eliminated the disease, making the certification a proof of concept for other tropical nations.
Nepal eliminates rubella, confirmed by the WHO
In August 2025, the World Health Organization confirmed Nepal’s elimination of rubella as a public health problem, making it the sixth nation in the WHO South-East Asia Region to reach this milestone. The achievement reflects more than a decade of vaccination campaigns and community outreach.
Vaccines and immunization: from first shots to global rollouts
Vaccination is the single most cost-effective tool in public health — and this group of stories spans from the pneumococcal vaccine’s 1977 licensing to 2025’s mRNA cancer trials, showing how the technology has compounded across generations. What connects them is not just the science but the systems built to deliver it to the most vulnerable populations.
The first pneumococcal vaccine is licensed in the United States
In 1977, the first modern pneumococcal vaccine was licensed in the United States, ending a century-long effort to tame one of humanity’s deadliest bacteria. Physician Robert Austrian had shown that many patients died within 96 hours of infection — before antibiotics could even help — making prevention essential.
WHO approves the world’s first malaria vaccine
After pilot programs delivered more than 2.3 million doses across Ghana, Kenya, and Malawi, the World Health Organization recommended RTS,S for broad use in sub-Saharan Africa. The shot targets the deadliest malaria parasite and represents one of the most complex vaccine development efforts in history.
Sudan launches its first malaria vaccine in a landmark child health initiative
Sudan became the first country in the WHO Eastern Mediterranean Region to launch the malaria vaccine nationally, reaching more than 148,000 children under 12 months in its opening phase. Remarkably, the rollout proceeded even as hospitals in parts of the country remained shuttered by conflict.
Malaria vaccine price cut will protect 7 million more children by 2030
A deal between Gavi and UNICEF reduced the cost of the R21/Matrix-M malaria vaccine by roughly 25%, dropping the price to under $4 per dose. The savings unlock more than 30 million additional doses, extending protection to an estimated 7 million additional children by 2030.
North Korea’s UNICEF-backed immunization campaign reaches all 210 counties
Backed by UNICEF, more than four million vaccine doses arrived in North Korea in July 2024 to jumpstart a nationwide immunization drive — reaching all 210 counties simultaneously and including pregnant women alongside children for the first time. It represents one of the most logistically complex vaccination efforts of recent years.
World’s first mRNA lung cancer vaccine enters human trials
BNT116, developed by BioNTech using the same mRNA technology behind COVID-19 vaccines, entered human trials in seven countries as the first mRNA vaccine specifically targeting lung cancer. The trial marks a historic expansion of vaccine technology from infectious disease into oncology.
Personalized mRNA vaccine keeps pancreatic cancer at bay six years on
Seven of eight pancreatic cancer patients who mounted an immune response to a personalized mRNA vaccine remain alive six years after treatment — extraordinary for one of medicine’s most stubborn killers. The results represent the most sustained evidence yet that mRNA technology can train the immune system to fight solid tumors.
Drug approvals and treatment breakthroughs: medicines changing outcomes
Each story in this section marks a moment when a disease that had resisted treatment for decades — or centuries — finally met a medicine equal to it. From dostarlimab eliminating rectal tumors in every trial participant to Japan’s first stem cell Parkinson’s therapy, these approvals represent the clinical payoff of decades of basic research.
Dostarlimab eliminates rectal tumors in all 42 trial patients
A cancer drug called dostarlimab earned FDA Breakthrough Therapy Designation after eliminating rectal tumors in all 42 patients who completed a Memorial Sloan Kettering trial, with some participants now cancer-free for up to four years. The drug works by helping the immune system recognize and attack cancer cells it had previously ignored.
FDA approves lenacapavir: a twice-yearly HIV prevention shot with 99.9%+ effectiveness
The FDA approved lenacapavir (brand name Yeztugo) as the first long-acting PrEP option in history, stopping HIV transmission in more than 99.9% of clinical trial participants. The twice-yearly injectable represents a fundamental shift in HIV prevention — replacing daily pills with a biannual shot.
Lenacapavir to be made cheaply available in 120 countries
Gilead Sciences licensed six generic manufacturers across India, Egypt, Pakistan, and the United States to produce lenacapavir affordably for distribution in 120 countries. The deal translates a near-perfect prevention tool from clinical trial results into a realistic global health intervention.
FDA approves first non-opioid pain drug in over 20 years
The FDA’s approval of Journavx (suzetrigine), developed by Vertex Pharmaceuticals, marks the most significant shift in acute pain treatment in over two decades. The drug blocks a specific sodium channel in the peripheral nervous system, stopping pain signals without the addiction risks of opioids.
Japan approves world’s first Parkinson’s stem cell treatment
Japan approved the world’s first iPSC-based stem cell therapy for Parkinson’s disease, developed at Kyoto University, offering new hope to an estimated 10 million patients globally. The treatment represents the first time iPSC technology has been approved for a neurodegenerative disease.
FDA approves wearable Onapgo device for continuous Parkinson’s management
Onapgo, a wearable device approved by the FDA, delivers a continuous under-skin infusion of apomorphine for Americans with Parkinson’s — bypassing the digestive system entirely for steadier symptom control. It offers a non-surgical alternative to deep brain stimulation for patients with advanced disease.
CAR T-cell therapy achieves lupus remission in all five trial patients
A small German trial used CAR T-cell therapy — originally developed for blood cancers — to reprogram patients’ own T-cells to clear out the malfunctioning B cells driving lupus, achieving remission in all five participants. The result opens a potential path to lasting remission in autoimmune diseases.
FDA approves first systemic drug for alopecia areata
Baricitinib became the first FDA-approved systemic treatment for alopecia areata, a condition affecting roughly 7 million Americans that had no approved drug option until now. The drug blocks the inflammatory signals that cause the immune system to attack hair follicles.
Global suicide rate has dropped nearly 40% since the 1990s
Global suicide rates have fallen nearly 40% since the early 1990s, dropping from roughly 15 to around 9 deaths per 100,000 people — one of modern public health’s most significant and underreported victories. The decline was driven by expanded mental health services, crisis intervention programs, and reduced access to lethal means.
Diagnostics, research tools, and frontier science
Treating disease depends on detecting it — and this group of stories tracks the diagnostic and research revolution running in parallel with therapeutic advances. From a blood test for early Parkinson’s to a single lab test that can identify virtually any pathogen, the tools of medicine are undergoing their own transformation.
Hong Kong researchers develop a nasal spray for stroke cutting brain damage 80%
Researchers at the University of Hong Kong developed a nasal spray that cut brain damage by more than 80% when given within 30 minutes of an ischemic stroke in preclinical studies. Tiny particles travel from the nose directly along nerve pathways to the brain, bypassing the blood-brain barrier.
Breakthrough genomic test identifies virtually any infection from one sample
A single lab test using metagenomic next-generation sequencing correctly identified 86% of neurological infections in a trial of nearly 5,000 patients at UC San Francisco, drawing from bacteria, viruses, fungi, and parasites simultaneously. The method could transform diagnosis for patients whose infections resist standard testing.
Blood test paves way for early Parkinson’s diagnosis before symptoms appear
Researchers at Kobe University developed a blood assay that reads changes in enzyme activity to detect Parkinson’s disease before symptoms take hold, achieving 85 to 88% accuracy in human and rat models. Earlier diagnosis could dramatically expand the window for intervention.
First biomarker found to identify babies at risk of SIDS
Australian scientists discovered that babies who died of SIDS had measurably lower levels of a specific enzyme present at birth, providing the first biological signal that distinguishes vulnerable infants from others. The finding opens a path toward targeted monitoring or intervention for at-risk newborns.
First COVID-19 breath test authorized by the FDA
The FDA authorized the first device capable of detecting COVID-19 from a single exhale, returning results in about three minutes by detecting a signature pattern of five compounds the body releases during infection. Made by InspectIR, it demonstrated that non-invasive virus detection was achievable.
Texas launches the largest state psychedelic research program in U.S. history
The Texas Legislature passed HB 3717 with bipartisan support, authorizing $50 million in supervised clinical trials of ibogaine — a plant-derived compound with promising results for addiction and PTSD — marking the largest state-funded psychedelic research initiative in U.S. history. The program reflects a broader shift in how governments are approaching mental health and addiction treatment.
First European psychedelic drug trial clinic opens in the U.K.
Clerkenwell Health opened as the first dedicated commercial psychedelic medicine clinic in Europe, moving the field from university labs into infrastructure built to carry compounds through late-stage trials. Its first focus is patients facing terminal diagnoses — a population with the most urgent unmet need.
British Columbia becomes the first Canadian province to decriminalize drug possession
British Columbia replaced arrest with referral to care for adults carrying small amounts of certain substances — one of the most significant public health pivots in Canadian history. The policy recognized that fear of police was keeping people from calling for help during overdoses.
Population health, equity, and the systems that protect everyone
The most transformative public health wins are not always a single drug or vaccine — sometimes they are a policy, a water pipe replacement, or a decision to make healthcare free. This section covers the systemic and equity-focused advances that determine whether individual medical breakthroughs actually reach the people who need them most.
Global child mortality falls from 48% to 27% by mid-20th century
Child mortality began its great retreat in the 18th and 19th centuries and reached a turning point by 1950, when roughly 27% of children still died before age five — down from an estimated 40–50% across most of human history. Clean water, vaccines, and improving nutrition each contributed to this foundational shift.
Global life expectancy crosses 50 years for the first time in history
Around 1955, global life expectancy crossed 50 years for the first time — a threshold earlier generations would have found almost unimaginable. The leap came simultaneously from antibiotics, mass vaccination, cleaner water, and steep drops in child mortality across Asia, Africa, and Latin America.
Global life expectancy rises by more than a decade since 1980
Between 1980 and 2015, global life expectancy climbed by more than a decade, with men reaching 69 years and women nearly 75, according to the Global Burden of Disease study. Childhood deaths halved since 1990, and malaria mortality dropped by roughly 60% after 2000.
Lead pollution in American bodies has dropped 100-fold over a century
Blood lead levels in U.S. residents have fallen roughly 100-fold over the past century, driven primarily by the phase-out of leaded gasoline and the 1978 federal ban on lead-based paint. It stands as one of the greatest environmental public health achievements in American history.
Flint replaces all lead pipes a decade after its water crisis
Michigan officials confirmed in a court filing that all 11,000 lead service lines in Flint have been replaced and more than 28,000 properties restored, fulfilling a core requirement of the city’s $26 million legal settlement. The milestone closes a chapter that exposed an entire American city to lead poisoning.
India’s Swachh Bharat Mission aims to end open defecation nationwide
Launched on Gandhi’s 150th birthday in October 2014, the Swachh Bharat Mission subsidized roughly 90 million toilets across India, and by 2022 the share of Indians practicing open defecation had dropped dramatically. The program represents one of the largest sanitation infrastructure efforts in human history.
Mexico launches universal healthcare for all 133 million citizens
Mexico launched a universal healthcare system through the restructured IMSS-Bienestar network, designed to cover all 133 million citizens. Before the reform, an estimated 50 million Mexicans had no formal health insurance, with rural and indigenous communities most severely underserved.
Finland’s free contraception initiative cuts teen abortion rate by 66%
Finland reduced its teen abortion rate by 66% over roughly two decades — one of the steepest drops ever recorded in a high-income country — by integrating no-cost birth control into the same youth clinics teenagers already used. The approach demonstrated that access, not just education, drives outcomes.
Botswana cuts mother-to-child HIV transmission from 40% to below 1%
Mother-to-child HIV transmission in Botswana plummeted from 40% in 1999 to below 1% today, with seven health districts recording zero cases in 2021. The success was built on three pillars: free testing, free antiretroviral treatment, and community health workers reaching women throughout pregnancy.
Tennessee becomes first U.S. state to provide free diapers through Medicaid
Tennessee will provide 100 free diapers per month through Medicaid for every child under two, in the first program of its kind in the country. Advocates project the program will deliver close to 100 million diapers a year, addressing a basic child health need that has long fallen outside public benefit programs.
Virginia gives nurse-midwives the right to practice without physician oversight
Virginia eliminated its physician supervision requirement for certified nurse-midwives, allowing them to practice independently — a change with particular significance for rural counties where obstetric services are scarce or absent. Research supports independent midwifery practice as safe and effective for low-risk pregnancies.
All 50 U.S. states now have rape kit reform laws after a 16-year campaign
With Maine’s new law on May 1, 2026, all 50 states, Washington D.C., and Puerto Rico now have at least one pillar of rape kit reform on the books. The 16-year campaign began when survivors started writing letters to advocate for testing backlogs to be cleared — a landmark in survivor-centered justice.
The Netherlands caps flights at Schiphol airport to cut pollution
The Netherlands became the first democratic government to hard-cap annual flights at a major airport — Europe’s third-busiest — treating aviation pollution the same way it would treat any other industrial emitter. The policy demonstrated that governments can impose binding environmental limits on the aviation sector.
China formalizes traditional medicine into a national health system in 1949
In 1949, China unified centuries of competing herbal traditions and folk practices into a single standardized system of traditional Chinese medicine. One legacy of that systematization is artemisinin — derived from an herb in the TCM pharmacopeia — which became the cornerstone of modern malaria treatment.
The first recorded cesarean birth with both mother and baby surviving
Around 1500 C.E., Swiss pig gelder Jacob Nufer reportedly performed a cesarean section on his wife after days of failed labor, and both mother and child survived — the first recorded case of a cesarean with dual survival. Whether or not every detail is accurate, the account marks the beginning of surgical thinking about birth complications.
U.K. cancer death rates reach their lowest level ever recorded
Cancer death rates in the United Kingdom have fallen to the lowest level ever recorded, according to Cancer Research UK data published in 2026. Age-standardized mortality rates dropped by more than 25% over the past two decades, driven by advances in lung, bowel, and breast cancer treatment and earlier detection.
The outlook
The pipeline has never looked more promising. mRNA platforms are being redirected from COVID-19 toward lung cancer, pancreatic cancer, and beyond. Japan’s approval of iPSC-based Parkinson’s therapy and the FDA’s approval of the first non-opioid acute pain drug in over two decades signal that fundamental biological problems once considered intractable are yielding.
The caveats are real. North Korea’s immunization reboot required years of diplomatic groundwork and remains fragile. Sudan’s malaria launch happened against a backdrop of shuttered hospitals. Progress is never automatic — it requires sustained funding, political will, and systems that reach the most vulnerable.
What these 60 stories collectively prove is that public health wins are not random. They follow investment, coordination, and the willingness to treat health as a shared public good rather than a private commodity. The question is not whether the tools exist — increasingly, they do — but whether the will to deploy them equitably persists.
Frequently asked questions
What are the biggest public health wins of recent years?
Among the most significant recent public health wins: the FDA’s approval of lenacapavir, an HIV prevention shot with over 99.9% effectiveness; WHO confirmation of Africa’s freedom from wild polio; the first WHO-recommended malaria vaccine now reaching children in sub-Saharan Africa and Sudan; global suicide rates down nearly 40% since the 1990s; and the first mRNA cancer vaccines entering human trials. Mexico’s launch of universal healthcare for 133 million citizens and Botswana’s reduction of mother-to-child HIV transmission from 40% to below 1% represent landmark equity advances.
Has any disease ever been fully eradicated?
Yes — smallpox is the only human infectious disease ever fully eradicated. It was declared eliminated on May 8, 1980, after a WHO campaign combining mass vaccination with intensive case-tracking. The disease had killed up to 30% of those it infected for at least 3,000 years before its eradication. Wild poliovirus has since been eliminated from Africa and most of the world, though it has not yet been globally certified as eradicated.
How did Finland reduce teenage abortions so dramatically?
Finland cut its teen abortion rate by 66% over roughly two decades by integrating free contraception into the same youth clinics teenagers already used for general health care. The approach showed that removing cost and stigma barriers — rather than relying on education alone — drives measurable outcomes. It’s considered one of the steepest drops in teen abortion rates ever recorded in a high-income country.
What is the current state of malaria vaccine access globally?
The WHO approved the RTS,S malaria vaccine for broad use in sub-Saharan Africa after pilot programs delivered more than 2.3 million doses across Ghana, Kenya, and Malawi. A newer vaccine, R21/Matrix-M, had its price cut by roughly 25% in a Gavi-UNICEF deal, unlocking over 30 million additional doses and projected to protect 7 million more children by 2030. Sudan became the first country in the WHO Eastern Mediterranean Region to launch a national malaria vaccine program in 2024.
How far have child mortality and life expectancy improved globally?
Child mortality has fallen from an estimated 40–50% across most of human history to roughly 27% by 1950, and has continued declining sharply since. Global life expectancy crossed 50 years for the first time around 1955, and by 2015 had risen by more than a decade since 1980, with men reaching 69 years and women nearly 75. Childhood deaths halved between 1990 and 2015, and malaria mortality dropped roughly 60% after 2000.
What is lenacapavir and why is it significant for HIV prevention?
Lenacapavir (brand name Yeztugo) is a twice-yearly injectable HIV prevention drug approved by the FDA in 2025, making it the first long-acting PrEP option in history. Clinical trials showed it stopped HIV transmission in more than 99.9% of participants — outperforming daily pill regimens. Gilead Sciences licensed six generic manufacturers to produce it affordably for distribution in 120 countries, making it a potential global game-changer for HIV prevention equity.
About this article
🤖 This article is AI-generated, based on a framework created by Peter Schulte.
🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
